Adverse Event reporting information can be found in footer

Request a Meeting

Propess Training and Resources


Propess is the first, single dose, retrievable vaginal insert for local, continuous and controlled release of dinoprostone in a retrievable and easy-to-use vaginal insert. Propess is indicated for the initiation of cervical ripening in patients at term (from 38th week of gestation).1




Propess is administered via a vaginal insert contained in a polyester pouch with a withdrawal tape. Propess releases dinoprostone at a constant and controlled rate.1


Where there is a need to terminate the drug administration, the dinoprostone vaginal insert can be easily retrieved, with the remaining dinoprostone in circulation rapidly cleared in 1-3 minutes.1


Propess Administration Video

Below is a short video showing the correct way to insert and remove Propess.

A link to the prescribing information can be found here.

The Induction of Labour Process

Below videos show a midwife explaining the induction of labour process to a woman who is about to be induced.

Within this section you will find a wealth of video resources, aimed at educating you and your patient on the current induction of labour guidance, explaining what induction of labour is, why it is offered and methods available.

What is induction of labour and why is it offered
What is membrane sweeping? - Here we explain a pre-induction method which is often used
What are prostaglandins? - Discover the role prostaglandins play in the softening of the cervix
What is artificial rupture of membranes? - Learn when this methods of induction is recommended
What is oxytocin? - Understand the role of oxytocin augmentation during induction
What are the mechanical methods to induce labour? - Learn the types of mechanical methods used during induction
What if nothing happens? - Discover how long it can take before labour is established after an induction
Induction of Labour - Frequently Asked Questions (Full Video)

If you would like to test your knowledge and understanding of Propess and how to administer Propess, please take the short quiz below.

Propess Quiz

Dinoprostone – The active substance is dinoprostone, more commonly known as Prostaglandin E2. Each vaginal delivery system contains 10 mg of dinoprostone which is released at approximately 0.3 mg per hour over 24 hours.

38 Weeks – Propess is licensed to be used after 37 completed weeks gestation.

In the freezer – Store in a freezer (-10ºC to -25°C). Store in the original container in order to protect from moisture. No thawing is required prior to use.

1-3 minutes – Propess has a half-life generally estimated as 1-3 minutes.

Immediately – Propess should be removed from the freezer just prior to the insertion. No thawing is required prior to use.

No – Do not use scissors or other sharp objects which may cut the retrieval system.

As high as possible – The vaginal delivery system should be inserted high into the posterior vaginal fornix and rotated so it sits transversely behind the posterior fornix

No – No attempt should be made to tuck the end of the tape into the vagina completely always leave a reasonable amount outside as this may make retrieval more difficult otherwise.

20-30 minutes – After insertion of Propess, the patient should be recumbent for 20 minutes to 30 minutes. As dinoprostone will be released continuously over a period of 24 hours, it is important to monitor uterine contractions and fetal condition at frequent regular interval.

  1. Onset of labour.
  2. Spontaneous rupture of the membranes or amniotomy.
  3. Evidence of fetal distress.
  4. Evidence of maternal systemic adverse dinoprostone effects such as nausea, vomiting, hypotension or tachycardia.
  5. At least 30 minutes prior to starting an intravenous infusion of oxytocin, as there is a much greater risk of hyperstimulation if the dinoprostone source is not ?
  6. 24 hours after insertion – The vaginal delivery system should be removed after 24 hours irrespective of whether cervical ripening has been achieved.


All of the above – correct answer.

Learn More

  1. Ferring Pharmaceuticals. Propess Summary of Product Characteristics. October 2021  last viewed on 018/10/21.

Job Code: UK-RMMH-2000023 - Date of preparation: March 2022


Our use of cookies

We use cookies (including third party cookies) to collect data while you use this website in order to make it work, keep it secure and comply with regulations. We’d also like your consent to use cookies so we can provide you with tailored content and advertising and analyse how you and other people use the website.

Select “On” to consent to our use of these cookies and continue to the website, or select “Off” to control which types of cookies we use. You can read more about cookies in our Privacy Policy.

Necessary cookies

Necessary cookies enable core functionality such as security, network management, and accessibility. You may disable these by changing your browser settings, but this may affect how the website functions.

Analytics cookies

We’d like to set Google Analytics cookies to help us to improve our website by collecting and reporting information on how you use it. The cookies collect information in away that does not directly identify anyone. For more information on how these cookies work, please see our Privacy Policy.